TABLE 5.
Clinical information of HB patient tissue samples used in IHC.
| Sample | UBE2C staining | Age at tx/res (years, age group) | Risk | Histology | Sex |
|---|---|---|---|---|---|
| HB1 | + | 3–7 | high | NA | F |
| HB2 | + | >7 | high | epithelial, macrotrabecular | M |
| HB3 | + | 1–3 | high | fetal epithelial, well differentiated | F |
| HB4 | + | 1–3 | high | embryonal and fetal epithelial | F |
| HB5 | + | >7 | high | fetal epithelial | M |
| HB6 | + | 1–3 | standard | mixed epithelial and mesenchymal | M |
| HB7 | + | 1–3 | standard | fetal epithelial | M |
| HB8 | − | 3–7 | high | fetal epithelial | F |
| HB9 | + | 3–7 | high | epithelial | F |
| HB10 | + | 1–3 | standard | fetal epithelial | M |
| HB11 | + | >7 | high | fetal epithelial | F |
| HB12 | + | >7 | high | fetal epithelial | M |
| HB13 | + | <1 | standard | fetal, teratoid features | M |
| HB14 | + | 1–3 | standard | fetal epithelial | M |
| HB15 | − | 1–3 | high | mixed epithelial and mesenchymal with teratoid features | F |
| HB16 | + | <1 | high | mixed epithelial and mesenchymal | M |
| HB17 | + | 1–3 | high | embryonal and fetal epithelial | M |
| HB18 | + | >7 | high | embryonal and fetal epithelial | F |
| HB19 | + | 3–7 | high | fetal epithelial | M |
| HB20 | - | >7 | high | embryonal and fetal epithelial | F |
| HB21 | + | 3–7 | high | embryonal and fetal epithelial | F |
| HB22 | − | 3–7 | high | fetal epithelial | M |
| HB23 | − | 3–7 | high | embryonal epithelial | F |
| HB24 | + | 3–7 | high | mixed | M |
| HB25 | + | 3–7 | high | fetal epithelial, well differentiated | M |